TRANSPLANT Act of 2021

Bill: 117-hr-941
Sponsor: Rep. Matsui, Doris O. [D-CA-6]
Introduced: 2021-02-08 in the House
Policy area: Health
Subjects: Advisory bodies
Blood and blood diseases
Cell biology and embryology
Congressional oversight
Government studies and investigations
Health programs administration and funding
Medical research
Organ and tissue donation and transplantation
Research administration and funding

Summary:
action_date: 2021-02-08
text: 

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

 
 
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
 
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
 
In addition, the Government Accountability Office must report on the regenerative medicine workforce.


action_date: 2021-04-15
text: 

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

 
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
 
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
 
In addition, the Government Accountability Office must report on the regenerative medicine workforce.
 

action_date: 2021-05-17
text: 

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

 
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
 
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
 
In addition, the Government Accountability Office must report on the regenerative medicine workforce.

action_date: 2021-05-26
text: 

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

 
This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.
 
The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.
 
In addition, the Government Accountability Office must report on the regenerative medicine workforce.


Legislative actions:
action_date: 2021-05-26
text: Became Public Law No: 117-15.
action_date: 2021-05-26
text: Became Public Law No: 117-15.
action_date: 2021-05-26
text: Signed by President.
action_date: 2021-05-26
text: Signed by President.
action_date: 2021-05-20
text: Presented to President.
action_date: 2021-05-20
text: Presented to President.
action_date: 2021-05-18
text: Message on Senate action sent to the House.
action_date: 2021-05-17
text: Passed Senate without amendment by Voice Vote.
action_date: 2021-05-17
text: Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
action_date: 2021-05-17
text: Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)
action_date: 2021-05-17
text: Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)
action_date: 2021-04-19
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-04-15
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2021-04-15
text: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)
action_date: 2021-04-15
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).(text: 04/14/2021 CR H1752-1753)
action_date: 2021-04-15
text: Considered as unfinished business. (consideration: CR H1829)
action_date: 2021-04-14
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2021-04-14
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 941.
action_date: 2021-04-14
text: Considered under suspension of the rules. (consideration: CR H1752-1754)
action_date: 2021-04-14
text: Mr. Pallone moved to suspend the rules and pass the bill.
action_date: 2021-02-09
text: Referred to the Subcommittee on Health.
action_date: 2021-02-08
text: Referred to the House Committee on Energy and Commerce.
action_date: 2021-02-08
text: Introduced in House
action_date: 2021-02-08
text: Introduced in House

Enacted as: number: 117-15